Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果